Comparative assessment of phenotypic markers in patients with chronic inflammation: Differences on <i>Bifidobacterium</i> concerning liver status

This study found phenotypical and microbial similarities and disparities between these two inflammatory conditions, evidenced in clinical and hepatic markers, and showed the interactive interplay between gut Bifidobacterium and liver health (measured by FLI) that occur in a different manner depending on the type of inflammatory disease. These results underscore the importance of personalized approaches and individual microbiota in the screening of different inflammatory situations, considering unique hepatic and microbiota profiles.

Authors

Institutions

Publication Details

Journal
European Journal of Clinical Investigation
Published
2024-10-28
DOI
https://doi.org/10.1111/eci.14339
Citations
3
Primary Topic
Gut microbiota and health
Type
article
Field-Weighted Citation Impact
0.70

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Comparative assessment of phenotypic markers in patients with chronic inflammation: Differences on Bifidobacterium concerning liver status

Andrea Higuera‐Gómez, María Martínez‐Urbistondo, Raquel Castejón, Susana Mellor‐Pita et al.
3 citations
European Journal of Clinical Investigation
Gut microbiota and health
0.70
article

Comparative assessment of phenotypic markers in patients with chronic inflammation: Differences on Bifidobacterium concerning liver status

Andrea Higuera‐Gómez, María Martínez‐Urbistondo, Raquel Castejón, Susana Mellor‐Pita, Daniel Antonio de Luis, Víctor Moreno‐Torres, Lourdes Chero‐Sandoval, J. Alfredo Martínéz, Amanda Cuevas‐Sierra
article en
3 citations

Abstract

This study found phenotypical and microbial similarities and disparities between these two inflammatory conditions, evidenced in clinical and hepatic markers, and showed the interactive interplay between gut Bifidobacterium and liver health (measured by FLI) that occur in a different manner depending on the type of inflammatory disease. These results underscore the importance of personalized approaches and individual microbiota in the screening of different inflammatory situations, considering unique hepatic and microbiota profiles.

European Journal of Clinical InvestigationVol. 55(2)
Madrid Institute for Advanced Studies (ES), Universidad de Valladolid (ES), Instituto de Salud Carlos III (ES), Spanish Biomedical Research Centre in Physiopathology of Obesity and Nutrition (ES), Hospital Universitario Puerta de Hierro Majadahonda (ES), Universidad Internacional De La Rioja (ES), IMDEA Food (ES), Universidad Autónoma de Madrid (ES)
Comunidad de Madrid, Consejería de Educación, Juventud y Deporte, Comunidad de Madrid, Instituto de Salud Carlos III
Good health and well-being
Openalex Percentile: Top 29%
Gut microbiota and health
0.70
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Comparative assessment of phenotypic markers in patients with chronic inflammation: Differences on <i>Bifidobacterium</i> concerning liver status — Andrea Higuera‐Gómez, María Martínez‐Urbistondo, et al. · European Journal of Clinical Investigation (2024) | TGRS Research Map | TGRS